Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18432350 | DISTRIBUTED COMPUTING SYSTEM FOR BLOOD PROCESSING PROCEDURES | February 2024 | August 2024 | Allow | 6 | 1 | 0 | No | No |
| 18339455 | PHARMACEUTICAL PACKAGING AND METHOD FOR DELIVERY OF SAME | June 2023 | September 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18134973 | REAL-TIME ECG REPORT GENERATION | April 2023 | May 2024 | Allow | 13 | 2 | 0 | Yes | Yes |
| 18183763 | Dynamically Controlled Treatment Protocols for Autonomous Treatment Systems | March 2023 | February 2024 | Allow | 11 | 0 | 0 | No | No |
| 18093144 | CARE PLAN ADMINISTRATION: PATIENT FEEDBACK | January 2023 | January 2024 | Allow | 12 | 1 | 0 | Yes | No |
| 17959923 | SYSTEM FOR IMMUTABILITY VERIFYING, RECORDING AND STORING DIGITAL REPRESENTATION OF OBJECTS AND EVENTS | October 2022 | March 2024 | Abandon | 17 | 2 | 0 | No | No |
| 17958289 | Novel Topical Therapy | September 2022 | December 2023 | Abandon | 14 | 1 | 0 | No | No |
| 17900624 | MANAGEMENT AND TRACKING OF PATIENT ENCOUNTERS AND MEDICAL INFORMATION INCLUDING IMMUTABLE TOKENS, DIGITAL ASSETS AND SMART CONTRACTS | August 2022 | December 2023 | Abandon | 15 | 2 | 0 | Yes | No |
| 17838146 | NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO ANTI-INFLAMMATORY THERAPIES FOR CARDIOVASCULAR DISEASE | June 2022 | June 2023 | Allow | 13 | 2 | 0 | Yes | No |
| 17838147 | NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO ANTI-DIABETIC THERAPIES FOR CARDIOVASCULAR DISEASE | June 2022 | July 2023 | Allow | 13 | 2 | 0 | Yes | No |
| 17706423 | DATA ABSTRACTION SYSTEM ARCHITECTURE NOT REQUIRING INTEROPERABILITY BETWEEN DATA PROVIDERS | March 2022 | May 2024 | Allow | 25 | 0 | 0 | No | No |
| 17697253 | METHODS AND SYSTEMS FOR REDUCING OPIOIDS FROM PAIN REGIMENS BY GRADUALLY REPLACING THE OPIOID DOSES WITH CANNABINOIDS | March 2022 | January 2024 | Abandon | 22 | 3 | 0 | Yes | No |
| 17579804 | Personalizing the Experience for the Senior Living Resident Through Automated Data Collection, Workflow Tools, and Actionable Insights | January 2022 | February 2024 | Abandon | 25 | 4 | 0 | Yes | No |
| 17573050 | DEVICES, SYSTEMS, AND METHODS FOR ADHERENCE MONITORING AND PATIENT INTERACTION | January 2022 | November 2023 | Allow | 22 | 1 | 0 | Yes | No |
| 17572103 | DEVICES, SYSTEMS, AND METHODS FOR ADHERENCE MONITORING AND PATIENT INTERACTION | January 2022 | November 2023 | Allow | 22 | 1 | 0 | Yes | No |
| 17541606 | SYSTEMS AND METHODS FOR SELECTING AN INTERVENTION BASED ON EFFECTIVE AGE | December 2021 | January 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17514303 | METHODS AND SYSTEMS FOR INFORMING PRODUCT DECISIONS | October 2021 | January 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17477745 | AUTOMATED IDENTIFICATION OF POTENTIAL DRUG SAFETY EVENTS | September 2021 | December 2023 | Abandon | 26 | 1 | 0 | No | No |
| 17461353 | METHOD AND SYSTEM FOR DESCRIBING AND RECOMMENDING OPTIMAL TREATMENT PLANS IN ADAPTIVE TELEMEDICAL OR OTHER CONTEXTS | August 2021 | April 2024 | Allow | 31 | 0 | 0 | No | No |
| 17366791 | COMPUTERIZED SYSTEM AND METHOD FOR MODIFYING COMPONENTS OF HEALTHCARE ORDERS WHICH ARE ASSOCIATED INTO CROSS-PHASE GROUPS | July 2021 | June 2024 | Allow | 35 | 2 | 0 | Yes | No |
| 17354882 | DISTRIBUTED COMPUTING SYSTEM FOR BLOOD PROCESSING PROCEDURES | June 2021 | April 2024 | Allow | 33 | 2 | 0 | No | No |
| 17315013 | CODE CART AND CODE CART SYSTEM | May 2021 | June 2024 | Abandon | 38 | 2 | 0 | No | No |
| 17206915 | SYSTEM AND METHOD FOR FUSING CLINICAL AND IMAGE FEATURES FOR COMPUTER-AIDED DIAGNOSIS | March 2021 | December 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17174092 | Genetic Based Health Management Systems for Weight and Nutrition Control | February 2021 | June 2024 | Abandon | 40 | 2 | 0 | No | No |
| 17162424 | SYSTEM, APPARATUS AND METHOD FOR SYNCHRONIZING DOSING EVENTS BETWEEN SPACES | January 2021 | March 2024 | Abandon | 38 | 3 | 0 | Yes | No |
| 17139995 | COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR TRACKING ENTITY LOCATION | December 2020 | May 2024 | Abandon | 40 | 2 | 0 | No | No |
| 17130873 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND SYSTEM | December 2020 | March 2024 | Abandon | 39 | 2 | 0 | Yes | No |
| 17128574 | TELEMEDICINE STETHOSCOPE DEVICE | December 2020 | April 2024 | Abandon | 39 | 2 | 0 | No | No |
| 17108793 | SYSTEMS AND METHODS FOR MANAGING REGIMEN ADHERENCE | December 2020 | July 2023 | Abandon | 31 | 1 | 0 | Yes | No |
| 16953256 | Dynamic Behavioral Phenotyping for Predicting Health Outcomes | November 2020 | July 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17099569 | COMPUTER-IMPLEMENTED SYSTEM AND METHOD FOR TRACKING PATIENT LOCATION | November 2020 | September 2024 | Abandon | 46 | 4 | 0 | Yes | No |
| 17086233 | Patient Outcome-Based Data Store | October 2020 | April 2023 | Abandon | 30 | 1 | 0 | No | No |
| 17068601 | DIGITAL PASS VERIFICATION SYSTEMS AND METHODS | October 2020 | January 2022 | Abandon | 15 | 2 | 0 | Yes | No |
| 17031013 | PHARMACEUTICAL PACKAGING AND METHOD FOR DELIVERY OF SAME | September 2020 | June 2023 | Abandon | 33 | 1 | 0 | No | No |
| 17026239 | METHODS FOR ADMINISTERING RESIDENTIAL CARE FACILITY | September 2020 | December 2022 | Abandon | 27 | 4 | 0 | Yes | No |
| 17015007 | Topical Therapy | September 2020 | November 2022 | Abandon | 27 | 1 | 0 | No | No |
| 17007004 | DYNAMICALLY CONTROLLED TREATMENT PROTOCOLS FOR AUTONOMOUS TREATMENT SYSTEMS | August 2020 | December 2022 | Allow | 27 | 0 | 0 | No | No |
| 16997287 | System and Method for Determining Operation of a Medical Device | August 2020 | September 2023 | Abandon | 37 | 2 | 0 | No | No |
| 16995782 | System and Method for Screening Potential Test Subjects for Participation in Recent Trials | August 2020 | September 2022 | Allow | 25 | 0 | 0 | No | No |
| 16944771 | METHODS FOR USING TEMPORARY INFORMATIONAL MARKINGS | July 2020 | January 2023 | Abandon | 30 | 1 | 0 | No | No |
| 16937998 | MONITORING, CAPTURING, MEASURING AND ANNOTATING PHYSIOLOGICAL WAVEFORM DATA | July 2020 | August 2024 | Abandon | 48 | 4 | 0 | Yes | No |
| 16947080 | IDENTIFICATION OF SURGERY CANDIDATES USING NATURAL LANGUAGE PROCESSING | July 2020 | August 2023 | Abandon | 37 | 2 | 0 | No | Yes |
| 16932659 | SYSTEMS AND METHODS FOR GENERATING OPTIMIZED SET OF PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PARAMETERS | July 2020 | March 2024 | Abandon | 44 | 4 | 0 | Yes | No |
| 16926149 | DATA ABSTRACTION SYSTEM ARCHITECTURE NOT REQUIRING INTEROPERABILITY BETWEEN DATA PROVIDERS | July 2020 | February 2022 | Allow | 19 | 2 | 0 | Yes | No |
| 16920836 | METHODS FOR ADMINISTERING RESIDENTIAL CARE FACILITY | July 2020 | August 2022 | Abandon | 25 | 4 | 0 | Yes | No |
| 16916946 | METHOD AND SYSTEM FOR REMOTE HEALTH MONITORING, ANALYZING, AND RESPONSE | June 2020 | February 2024 | Abandon | 43 | 3 | 0 | No | No |
| 16957261 | SIGNAL-PROCESSING DEVICE, ANALYSIS SYSTEM, SIGNAL-PROCESSING METHOD, AND SIGNAL-PROCESSING PROGRAM | June 2020 | December 2023 | Abandon | 42 | 2 | 0 | Yes | No |
| 16874353 | CARE PLAN ADMINISTRATION: PATIENT FEEDBACK | May 2020 | September 2022 | Allow | 28 | 1 | 0 | No | No |
| 15931517 | Medication Management Among A Network of Medical Entities | May 2020 | September 2023 | Abandon | 40 | 2 | 0 | No | No |
| 15931402 | ESTIMATING IMPACT OF PROPERTY ON INDIVIDUAL HEALTH - PROPERTY SCORE | May 2020 | November 2022 | Allow | 31 | 1 | 0 | No | No |
| 16856985 | METHOD AND SYSTEM FOR DESCRIBING AND RECOMMENDING OPTIMAL TREATMENT PLANS IN ADAPTIVE TELEMEDICAL OR OTHER CONTEXTS | April 2020 | March 2021 | Allow | 10 | 2 | 0 | Yes | No |
| 16784061 | SYSTEM FOR ADMINISTERING A MEDICAMENT | February 2020 | December 2022 | Allow | 34 | 1 | 0 | No | No |
| 16774418 | THERAPY PROGRAM SELECTION FOR ELECTRICAL STIMULATION THERAPY BASED ON A VOLUME OF TISSUE ACTIVATION | January 2020 | January 2023 | Allow | 36 | 1 | 0 | No | No |
| 16733156 | CLINICAL DASHBOARD FOR MEDICAL DEVICE | January 2020 | March 2023 | Abandon | 38 | 2 | 0 | Yes | No |
| 16729326 | METHODS AND SYSTEMS FOR INFORMING PRODUCT DECISIONS | December 2019 | September 2021 | Allow | 20 | 2 | 0 | No | Yes |
| 16701196 | METHOD OF PREDICTING AND MITIGATING ADVERSE EVENTS | December 2019 | May 2021 | Allow | 17 | 1 | 0 | No | No |
| 16684513 | NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM STORING ALLERGY PRESCRIPTION SEARCH PROGRAM | November 2019 | January 2023 | Abandon | 38 | 2 | 0 | No | No |
| 16657457 | SYSTEMS AND METHODS FOR MEDICATION ADHERENCE | October 2019 | February 2024 | Abandon | 52 | 4 | 0 | Yes | No |
| 16565383 | SYSTEMS AND METHODS OF MONITORING MEDICATION COMPLIANCE | September 2019 | November 2022 | Abandon | 39 | 1 | 0 | No | No |
| 16558502 | SYSTEMS AND METHODS FOR SELECTING AN INTERVENTION BASED ON EFFECTIVE AGE | September 2019 | September 2021 | Allow | 24 | 2 | 0 | Yes | No |
| 16449228 | DATA ABSTRACTION SYSTEM ARCHITECTURE NOT REQUIRING INTEROPERABILITY BETWEEN DATA PROVIDERS | June 2019 | September 2020 | Abandon | 15 | 2 | 0 | Yes | No |
| 16439077 | SYSTEMS FOR MAKING PERSONALIZED MEDICINE | June 2019 | April 2023 | Abandon | 46 | 2 | 0 | Yes | No |
| 16396835 | IDENTIFICATION OF SURGERY CANDIDATES USING NATURAL LANGUAGE PROCESSING | April 2019 | February 2022 | Abandon | 33 | 4 | 0 | No | Yes |
| 16387291 | HEALTH-CARE E-COMMERCE SYSTEMS AND METHODS | April 2019 | May 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16374648 | DENTAL CONDITION EVALUATION AND TREATMENT | April 2019 | May 2023 | Abandon | 49 | 6 | 0 | Yes | No |
| 16363337 | ADAPTING THE DISPLAY OF PATIENT DATA BASED ON DISPLAY SCREEN-REAL ESTATE AND PATIENT MONITORING CONTEXT | March 2019 | April 2023 | Abandon | 49 | 2 | 0 | Yes | No |
| 16360061 | AUTOMATED IDENTIFICATION OF POTENTIAL DRUG SAFETY EVENTS | March 2019 | January 2022 | Abandon | 34 | 2 | 0 | Yes | No |
| 16360577 | PATIENT CARE INTEGRATION SYSTEM AND METHODS | March 2019 | January 2024 | Abandon | 58 | 2 | 0 | Yes | Yes |
| 16360747 | System and Method for Assessing Heart Health and Communicating the Assessment to a Patient | March 2019 | September 2022 | Abandon | 42 | 1 | 0 | No | No |
| 16332826 | CONTROLLING CLOUD-BASED IMAGE PROCESSING BY ASSURING DATA CONFIDENTIALITY | March 2019 | December 2021 | Allow | 33 | 2 | 0 | Yes | No |
| 16352720 | AUTOMATED ADAPTATION OF PATIENT ASSESSMENT REPORT FORMAT | March 2019 | November 2021 | Abandon | 32 | 1 | 0 | Yes | No |
| 16351303 | Data Management for Genetic Laboratory Testing | March 2019 | May 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16351091 | DIGITAL BIOMARKERS FOR PROGRESSING MS | March 2019 | April 2022 | Allow | 37 | 2 | 0 | Yes | No |
| 16299077 | HEALTHCARE PRESCRIPTION DELIVERY TECHNIQUES USING A MONEY TRANSFER NETWORK | March 2019 | September 2020 | Abandon | 18 | 1 | 0 | No | No |
| 16294477 | RECORDING MEDIUM RECORDING SIMILAR CASE RETRIEVAL PROGRAM, INFORMATION PROCESSING APPARATUS, AND SIMILAR CASE RETRIEVAL METHOD | March 2019 | May 2021 | Abandon | 26 | 1 | 0 | No | No |
| 16288929 | COGNITIVE ANALYSIS PROCESSING TO FACILITATE SCHEDULE PROCESSING AND SUMMARIZATION OF ELECTRONIC MEDICAL RECORDS | February 2019 | January 2024 | Abandon | 58 | 6 | 0 | Yes | No |
| 16284704 | System and Method for Using Decision Rules to Identify and Abstract Data from Electronic Health Sources | February 2019 | March 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16277330 | MEDICAL DOCUMENT CREATION SUPPORT APPARATUS, METHOD, AND PROGRAM | February 2019 | February 2023 | Abandon | 48 | 4 | 0 | Yes | No |
| 16276507 | Computing Devices with Improved User Interfaces for Applications | February 2019 | February 2021 | Abandon | 24 | 1 | 0 | No | No |
| 16325489 | SYSTEM AND METHOD FOR DIAGNOSING AND ASSESSING THERAPEUTIC EFFICACY OF MENTAL DISORDERS | February 2019 | June 2023 | Abandon | 52 | 4 | 0 | Yes | No |
| 16325646 | KNOWLEDGE DISCOVERY FROM SOCIAL MEDIA AND BIOMEDICAL LITERATURE FOR ADVERSE DRUG EVENTS | February 2019 | February 2021 | Abandon | 24 | 1 | 0 | No | No |
| 16324959 | METHOD OF EVALUATING THERAPEUTIC EFFECT OF DRUG IN CANCER PATIENT, METHOD OF GENERATING EVALUATION DATA OF THERAPEUTIC EFFECT, THERAPEUTIC EFFECT EVALUATION DEVICE, AND THERAPEUTIC EFFECT EVALUATION PROGRAM | February 2019 | January 2024 | Abandon | 59 | 6 | 0 | Yes | No |
| 16273475 | METHODS AND SYSTEMS FOR PREDICTING CLINICAL TRIAL CRITERIA USING MACHINE LEARNING TECHNIQUES | February 2019 | December 2022 | Abandon | 46 | 4 | 0 | Yes | No |
| 16268575 | SYSTEM AND METHOD FOR STORING AND DELIVERING HEALTHCARE INFORMATICS DATA | February 2019 | February 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16227773 | SYSTEM AND METHOD FOR IMPROVING HEALTHCARE THROUGH SOCIAL ROBOTICS | December 2018 | January 2021 | Allow | 25 | 1 | 0 | No | No |
| 16350547 | Dynamic balance adjustment estimator engine | December 2018 | May 2023 | Abandon | 53 | 6 | 0 | Yes | No |
| 16185245 | METHOD, APPARATUS AND SYSTEM FOR RENDERING AND DISPLAYING MEDICAL IMAGES | November 2018 | February 2021 | Abandon | 27 | 1 | 0 | No | No |
| 16176150 | METHOD AND MOBILE APPLICATION FOR OPTIMIZING INFANT FEEDING PLAN | October 2018 | July 2021 | Abandon | 33 | 2 | 0 | No | No |
| 16176691 | Unsaleable Pharmaceutical Item Handling and Disposal Systems, Methods, and Devices | October 2018 | February 2021 | Abandon | 27 | 1 | 0 | No | No |
| 16173619 | SYSTEM AND METHOD FOR GENERATING A CARE SERVICES COMBINATION FOR A USER | October 2018 | October 2021 | Abandon | 36 | 2 | 0 | Yes | Yes |
| 16170775 | SYSTEMS AND METHODS FOR MEDICAL INSTRUMENT PATIENT MEASUREMENTS | October 2018 | February 2021 | Abandon | 27 | 4 | 0 | No | Yes |
| 16143160 | METHOD AND APPARATUS FOR MONITORING MEDICATION ADHERENCE | September 2018 | November 2022 | Abandon | 50 | 3 | 0 | Yes | No |
| 16080613 | Connected Healthcare Environment | August 2018 | April 2024 | Abandon | 60 | 2 | 0 | No | Yes |
| 16059967 | AUTOMATED CLINICAL DOCUMENTATION SYSTEM AND METHOD | August 2018 | November 2022 | Abandon | 51 | 4 | 0 | Yes | Yes |
| 16066229 | METHOD AND APPARATUS FOR MONITORING A SUBJECT | June 2018 | July 2021 | Abandon | 36 | 2 | 0 | No | No |
| 16061401 | DEVICE, SYSTEM, AND METHOD FOR OPTIMIZING A HEALTHCARE NETWORK | June 2018 | December 2021 | Abandon | 42 | 2 | 0 | No | No |
| 15977690 | SYSTEMS AND METHODS FOR MANAGING DATA PRIVACY | May 2018 | August 2020 | Abandon | 27 | 4 | 0 | Yes | No |
| 15959558 | SYSTEM AND METHOD FOR DISPLAYING DISCHARGE INSTRUCTIONS FOR A PATIENT | April 2018 | November 2020 | Abandon | 30 | 1 | 0 | No | No |
| 15769756 | INTEGRATED HEALTHCARE PERFORMANCE ASSESSMENT TOOL FOCUSED ON AN EPISODE OF CARE | April 2018 | August 2023 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 15955084 | Pharmaceutical Packaging and Method for Delivery of Same | April 2018 | December 2020 | Abandon | 32 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner COLEMAN, CHARLES P..
With a 20.4% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 15.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner COLEMAN, CHARLES P. works in Art Unit 3626 and has examined 491 patent applications in our dataset. With an allowance rate of 13.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 50 months.
Examiner COLEMAN, CHARLES P.'s allowance rate of 13.0% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by COLEMAN, CHARLES P. receive 3.33 office actions before reaching final disposition. This places the examiner in the 92% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by COLEMAN, CHARLES P. is 50 months. This places the examiner in the 6% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +17.9% benefit to allowance rate for applications examined by COLEMAN, CHARLES P.. This interview benefit is in the 60% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 2.3% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 7.7% of cases where such amendments are filed. This entry rate is in the 8% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 61.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 51% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 37.2% of appeals filed. This is in the 6% percentile among all examiners. Of these withdrawals, 46.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 53.5% are granted (fully or in part). This grant rate is in the 54% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 34% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 37% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.